Tag: Sofia
Microvention announces publication of SOFAST clinical data
Microvention, a wholly owned subsidiary of Terumo Corporation, has today announced the publication of data from SOFAST—a prospective, multicentre US study assessing the efficacy...
New SOFAST data show high technical success and first-pass rates with...
Fresh data from the SOFAST study have indicated high rates of technical success and first-pass reperfusion with the Sofia 6Fr Flow Plus aspiration catheter...
Microvention celebrates 10 years and more than 500,000 procedures with Sofia...
Microvention, a wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation commemorating the anniversary of its Sofia and Sofia Flow...
Microvention enters transradial access market with US FDA clearance of Sofia...
Microvention, a wholly owned subsidiary of Terumo Corporation, announced today that the Sofia EX 5Fr 115cm intracranial support catheter received US Food and Drug...
FDA clearance for SOFIA thrombectomy device
MicroVention has announced the US FDA clearance of a new clinical indication for the SOFIA Catheter (Soft TOrqueable catheter For Intracranial Access) to include...
